Return to Trial Database

TBCRC046

A Phase II Trial of Avelumab or Hydroxychloroquine with or without Palbociclib to Eliminate Dormant Breast Cancer (“PALAVY”)

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial TBCRC046 being conducted in.

Dana-Farber Cancer Institute

Fred Hutchinson Cancer Research Center

Georgetown Lombardi Comprehensive Cancer Center

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Penn Medicine Abramson Cancer Center

The University of Chicago Medicine Comprehensive Cancer Center

Vanderbilt-Ingram Cancer Center